Advances in the treatment of children with human immunodeficiency virus infection

George McSherry, E. Connor

Research output: Contribution to journalReview article

Abstract

Over the past decade a number of significant advances have been made in the diagnosis and management of human immunodeficiency virus infection in children. Using virologic methods, it is now possible to make a specific diagnosis within the first few months after birth (more than 95% of infected children can be diagnosed by 3 to 6 months of age). In addition, a better understanding of the normal 'development' of CD4 lymphocyte counts in infants and children has shown that these values are distinctly different than in adults and that values change with advancing age. This is important in monitoring human immunodeficiency virus-infected children and in determining thresholds for instituting intervention strategies. Human immunodeficiency virus infection in children is now a treatable disease. Two antiretroviral agents have been approved for use in pediatric patients and a host of studies are underway to investigate the optimal regimens of these agents and alternative new agents. Standard recommendations are in place for prevention of Pneumocystis carinii pneumonia, the most common and often fatal opportunistic infection in human immunodeficiency virus-infected children. Advances have been made in supportive cae, including the prevention of bacterial infections in some categories of patients.

Original languageEnglish (US)
Pages (from-to)588-595
Number of pages8
JournalCurrent Opinion in Infectious Diseases
Volume5
Issue number4
DOIs
StatePublished - Jan 1 1992

Fingerprint

Virus Diseases
HIV
Therapeutics
Anti-Retroviral Agents
Pneumocystis Pneumonia
Opportunistic Infections
CD4 Lymphocyte Count
Bacterial Infections
Parturition
Pediatrics

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{f1a4e362b07e4d01a2948ba41ebbc6bf,
title = "Advances in the treatment of children with human immunodeficiency virus infection",
abstract = "Over the past decade a number of significant advances have been made in the diagnosis and management of human immunodeficiency virus infection in children. Using virologic methods, it is now possible to make a specific diagnosis within the first few months after birth (more than 95{\%} of infected children can be diagnosed by 3 to 6 months of age). In addition, a better understanding of the normal 'development' of CD4 lymphocyte counts in infants and children has shown that these values are distinctly different than in adults and that values change with advancing age. This is important in monitoring human immunodeficiency virus-infected children and in determining thresholds for instituting intervention strategies. Human immunodeficiency virus infection in children is now a treatable disease. Two antiretroviral agents have been approved for use in pediatric patients and a host of studies are underway to investigate the optimal regimens of these agents and alternative new agents. Standard recommendations are in place for prevention of Pneumocystis carinii pneumonia, the most common and often fatal opportunistic infection in human immunodeficiency virus-infected children. Advances have been made in supportive cae, including the prevention of bacterial infections in some categories of patients.",
author = "George McSherry and E. Connor",
year = "1992",
month = "1",
day = "1",
doi = "10.1097/00001432-199208000-00016",
language = "English (US)",
volume = "5",
pages = "588--595",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Advances in the treatment of children with human immunodeficiency virus infection. / McSherry, George; Connor, E.

In: Current Opinion in Infectious Diseases, Vol. 5, No. 4, 01.01.1992, p. 588-595.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Advances in the treatment of children with human immunodeficiency virus infection

AU - McSherry, George

AU - Connor, E.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Over the past decade a number of significant advances have been made in the diagnosis and management of human immunodeficiency virus infection in children. Using virologic methods, it is now possible to make a specific diagnosis within the first few months after birth (more than 95% of infected children can be diagnosed by 3 to 6 months of age). In addition, a better understanding of the normal 'development' of CD4 lymphocyte counts in infants and children has shown that these values are distinctly different than in adults and that values change with advancing age. This is important in monitoring human immunodeficiency virus-infected children and in determining thresholds for instituting intervention strategies. Human immunodeficiency virus infection in children is now a treatable disease. Two antiretroviral agents have been approved for use in pediatric patients and a host of studies are underway to investigate the optimal regimens of these agents and alternative new agents. Standard recommendations are in place for prevention of Pneumocystis carinii pneumonia, the most common and often fatal opportunistic infection in human immunodeficiency virus-infected children. Advances have been made in supportive cae, including the prevention of bacterial infections in some categories of patients.

AB - Over the past decade a number of significant advances have been made in the diagnosis and management of human immunodeficiency virus infection in children. Using virologic methods, it is now possible to make a specific diagnosis within the first few months after birth (more than 95% of infected children can be diagnosed by 3 to 6 months of age). In addition, a better understanding of the normal 'development' of CD4 lymphocyte counts in infants and children has shown that these values are distinctly different than in adults and that values change with advancing age. This is important in monitoring human immunodeficiency virus-infected children and in determining thresholds for instituting intervention strategies. Human immunodeficiency virus infection in children is now a treatable disease. Two antiretroviral agents have been approved for use in pediatric patients and a host of studies are underway to investigate the optimal regimens of these agents and alternative new agents. Standard recommendations are in place for prevention of Pneumocystis carinii pneumonia, the most common and often fatal opportunistic infection in human immunodeficiency virus-infected children. Advances have been made in supportive cae, including the prevention of bacterial infections in some categories of patients.

UR - http://www.scopus.com/inward/record.url?scp=0026713901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026713901&partnerID=8YFLogxK

U2 - 10.1097/00001432-199208000-00016

DO - 10.1097/00001432-199208000-00016

M3 - Review article

AN - SCOPUS:0026713901

VL - 5

SP - 588

EP - 595

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 4

ER -